Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cellybri Advanced Therapies is a Brazilian healthcare company focused on commercializing health products, medical devices, and nutritional supplements rather than a traditional therapeutic drug pipeline. The company traces its origins to a 2011 business founded as DMPZ Comercial, Importadora e Exportadora and was restructured under new control in October 2019, when it adopted the Cellybri name. Its portfolio includes graduated compression stockings for vascular care under the Segreta brand and nutrition-oriented products such as Presigia, Celdersen, Angiovance, and Vancelipo. Cellybri positions itself around angiologia, nutrition, and broader health and wellness solutions for the Brazilian market. Based on currently available public information, it appears to be a commercial-stage private healthcare products company rather than a clinical-stage biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cellybri Advanced Therapies.